Brett King, MD: Deuruxolitinib Approval and the 'Golden Age' of Alopecia Areata
HCPLive
JULY 27, 2024
Brett King, MD, PhD, discusses how the deuruxolitinib approval impacts the treatment landscape of alopecia areata.
Sat.Jul 27, 2024
111 
Can App Data Link Sleep and Chronic Disease?; AI Model to Manage Diabetes
Med Page Today
JULY 27, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
10-Year Mortality in Patients Undergoing PCI for First-Time ST-Segment Elevation Myocardial Infarction
NEJM Journal Watch - Cardiology
JULY 27, 2024
In a large observational study, patients who survived to three months had only slightly higher 10-year mortality compared with the general population.
PVCs with VA conduction
ECG Guru
JULY 27, 2024
Why is the pause after the PVCs relatively long? We see a sinus arrhythmia in the rhythm strip. The ventricular extrasystoles penetrate the AV node retrogradely and reset the sinus rhythm, which then restarts.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Medicare Claims for Opioid Use Disorder Medications Spike Post-Coverage Update
HCPLive
JULY 27, 2024
A new study found claims for services of opioid treatment programs rose among Medicare beneficiaries after Medicare started covering them.
Targeting Inflammation May Not Impact Hepatic Fibrosis in MASLD, Study Finds
HCPLive
JULY 27, 2024
Findings suggest the current emphasis on targeting inflammation to mitigate fibrosis in MASLD may be incorrect, citing the minimal impact of LBP function loss on fibrosis.
Let's personalize your content